NCT06258642 2025-08-20Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCFudan UniversityPhase NA Recruiting39 enrolled
NCT06749691 2024-12-27LIAESSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting30 enrolled